SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000812796-07-000073
Filing Date
2007-08-17
Accepted
2007-08-17 17:05:19
Documents
1
Effectiveness Date
2007-08-17

Document Format Files

Seq Description Document Type Size
1 NOTICE OF INTERNET AVAILABILITY OF PROXY MATERIALS defa14anoticeofannual.htm DEFA14A 29451
  Complete submission text file 0000812796-07-000073.txt   31063
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-16929 | Film No.: 071065791
SIC: 2834 Pharmaceutical Preparations